Quest Diagnostics (DGX) Operating Leases (2019 - 2026)

Quest Diagnostics has reported Operating Leases for 8 years, with the latest figure at $561.0 million in Q2 2026.

• Quarterly Operating Leases rose 3.89% year-over-year to $561.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $561.0 million (up 3.89% YoY) and the FY2025 annual result came in at $537.0 million, down 25.93% from the prior year.
• Operating Leases declined to $561.0 million in Q2 2026 per DGX's latest filing, from $574.0 million in the prior quarter.
• Over five years, Operating Leases peaked at $725.0 million in Q4 2024 and troughed at $489.0 million in Q1 2024.
• A 5-year average of $549.4 million and a median of $535.5 million in 2025 frame the typical range for Operating Leases.
• The widest YoY moves for Operating Leases: up 10.02% in 2025, down 25.93% in 2025.
• Over 5 years, Operating Leases stood at $651.0 million in 2022, then climbed by 1.84% to $663.0 million in 2023, then rose by 9.35% to $725.0 million in 2024, then fell by 25.93% to $537.0 million in 2025, then advanced by 4.47% to $561.0 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $561.0 million, $574.0 million, and $537.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.